In this issue of Dermatology Times, we discuss the efficacy of CBD-containing dermatology products on the market. We also highlight the need to shift AD management from a rescue approach for flares to treatments that suppress the underlying pathophysiology and promote long-term disease control. We continue to cover therapeutic advances in psoriasis, acne and skin cancer and investigate how erythema impacts the quality of life of rosacea patients. Read these and other stories from the issue here
 
Dermatology Times cover
Are CBD skincare products effective?
A variety of topical CBD products are becoming increasingly available to patients, but do they actually work? These experts believe more research is needed to create CBD-containing dermatology products that can effectively treat skin disorders.
Re-think rescue approach in AD
Dermatologists should not depend on a rescue approach for atopic dermatitis flares, says a recent paper. Instead, they should talk with patients about newer treatment options that could offer long-term disease control with minimal adverse events.
Leg psoriasis improves with topical lotion
Topical halobetasol propionate 0.01% lotion appears to safely and quickly improve lower-extremity psoriatic lesions, according to a recent study.
Erythema severity mirrors quality-of-life impact in rosacea
A web-based survey indicates erythema severity correlates with rosacea’s quality-of-life impact.

Connect with us on Twitter and Facebook for daily updates.